Boston, MA 05/28/2013 (wallstreetpr) – The share prices of BSD Medical Corporation (NASDAQ:BSDM) had declined by 7.46 percent to close at $1.24 per share for the end of last trading session. The shares of the pharmaceutical company had been trading in the range of $1.20 to $1.38 per share during the day. BSD Medical Corporation (NASDAQ:BSDM) has a 52 week low price level of $0.76 per share and 52 week high price level of $2.41 per share.
Sale of treatment system to University Hospital
BSD Medical Corporation (NASDAQ:BSDM) had been involved in the development and distribution of treatment systems for cancer based on radiofrequency and microwave energy. The pharmaceutical company had recently announced that it had sold its MicrothermX to the University Hospital in New Jersey. MicroThermX of BSD Medical Corporation (NASDAQ:BSDM) is a unique, state – of – the – art proprietary system which uses synchronous phased array technology to provide wide range of uniform zones of ablation.
The business of BSD Medical Corporation (NASDAQ:BSDM) focuses on commercialization of treatment therapy for cancer using radiofrequency and microwave energy. The pharmaceutical company is involved in the development and distribution of treatment therapies to hospitals and clinics for thermal treatment of cancer using microwave or RF systems. The hyperthermia treatment systems developed by BSD Medical Corporation (NASDAQ:BSDM) are used to treat cancer with heat.
BSD Medical Corporation (NASDAQ:BSDM) presently holds 29.75 million shares outstanding and the institutional ownership in the company is 6 percent of the holdings. The average trading volume of the company is 264,175 shares per day.
